Updated on: May 25, 2022
This updated BCCDC guidance document addresses key therapeutic areas of concern for clinicians with recommendations sorted by severity of patient illness.
Antimicrobial and Immunomodulatory Therapy
Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.